These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 2025787

  • 1. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.
    Lupien PJ, Brun D, Gagné C, Moorjani S, Bielman P, Julien P.
    Can J Cardiol; 1991; 7(1):27-33. PubMed ID: 2025787
    [Abstract] [Full Text] [Related]

  • 2. Changes in serum and lipoprotein lipids, and apolipoprotein B and A-I, in patients with different types of primary hyperlipoproteinaemia treated with gemfibrozil.
    Sommariva D, Branchi A, Pini C, Scandiani L, Orlandi S, Fasoli A.
    Int J Clin Pharmacol Res; 1988; 8(5):383-92. PubMed ID: 3068163
    [Abstract] [Full Text] [Related]

  • 3. [Effects of bezafibrate on lipoprotein lipids and apolipoproteins B and A1 in patients with primary hypercholesterolemia].
    Branchi A, Sommariva D, Tirrito M, Bonfiglioli D, Pini C, Scandiani L, Orlandi S, Fasoli A.
    Clin Ter; 1987 Jul 15; 122(1):17-23. PubMed ID: 2973892
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gemfibrozil in hyperlipidaemia: an open, single blind trial.
    Varthakavi PK, Turakhia DP, Sharma SS, Salgaonkar DS, Nihalani KD, Joshi VR.
    J Assoc Physicians India; 1990 Feb 15; 38(2):136-40. PubMed ID: 2380132
    [Abstract] [Full Text] [Related]

  • 8. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
    Tamai T, Nakai T, Yamada S, Kobayashi T, Hayashi T, Kutsumi Y, Takeda R.
    Artery; 1979 Feb 15; 5(2):125-43. PubMed ID: 231951
    [Abstract] [Full Text] [Related]

  • 9. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
    Superko HR, Garrett BC, King SB, Momary KM, Chronos NA, Wood PD.
    Am J Cardiol; 2009 Feb 01; 103(3):387-92. PubMed ID: 19166694
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG, Patel ST, Falko JM, Newman HA, Hill DS.
    J Clin Endocrinol Metab; 1982 Jun 01; 54(6):1210-5. PubMed ID: 7076797
    [Abstract] [Full Text] [Related]

  • 12. Fenofibrate of gemfibrozil for treatment of types IIa and IIb primary hyperlipoproteinemia: a randomized, double-blind, crossover study.
    Insua A, Massari F, Rodríguez Moncalvo JJ, Rubén Zanchetta J, Insua AM.
    Endocr Pract; 2002 Jun 01; 8(2):96-101. PubMed ID: 11942772
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Management of primary mixed hyperlipidemia with lovastatin.
    Vega GL, Grundy SM.
    Arch Intern Med; 1990 Jun 01; 150(6):1313-9. PubMed ID: 2353864
    [Abstract] [Full Text] [Related]

  • 15. Reversible increase of the apo CII/apo CIII-1 ratio in the very low density lipoproteins after procetofen treatment in hypertriglyceridemic patients.
    Franceschini G, Sirtori M, Gianfranceschi G, Frosi T, Montanari G, Sirtori CR.
    Artery; 1985 Jun 01; 12(6):363-81. PubMed ID: 4051756
    [Abstract] [Full Text] [Related]

  • 16. Gemfibrozil also corrects dyslipidemia in postmenopausal women and smokers.
    Koskinen P, Kovanen PT, Tuomilehto J, Manninen V.
    Arch Intern Med; 1992 Jan 01; 152(1):90-6. PubMed ID: 1728934
    [Abstract] [Full Text] [Related]

  • 17. Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels.
    Schaefer EJ, Lamon-Fava S, Cole T, Sprecher DL, Cilla DD, Balagtas CC, Rowan JP, Black DM.
    Atherosclerosis; 1996 Nov 15; 127(1):113-22. PubMed ID: 9006811
    [Abstract] [Full Text] [Related]

  • 18. [Effect of bezafibrate on serum lipid, lipoprotein and apoprotein levels in patients with hyperlipoproteinemia type II and IV].
    Bednarska-Makaruk M, Kuźmińska A, Chotkowska E, Kurjata P, Polakowska M, Broda G, Rywik S.
    Pol Arch Med Wewn; 1992 Mar 15; 87(3):149-56. PubMed ID: 1523145
    [Abstract] [Full Text] [Related]

  • 19. Lipoprotein profiling by high performance gel chromatography.
    Tallis GA, Shephard MD, Whiting MJ.
    Clin Chim Acta; 1994 Aug 15; 228(2):171-9. PubMed ID: 7988033
    [Abstract] [Full Text] [Related]

  • 20. Effects of CS-514, a new inhibitor of HMG CoA reductase, on plasma lipids, lipoproteins and apoproteins in patients with primary hypercholesterolemia.
    Kazumi T, Yoshino G, Kasama T, Iwatani I, Iwai M, Morita S, Baba S.
    Horm Metab Res; 1986 Sep 15; 18(9):654-5. PubMed ID: 3096862
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.